Multiple DNA and nucleotide synthesis-related sites

The term Multiple DNA and nucleotide synthesis-related sites refers to a collective group of enzymes and molecular processes essential for the production of deoxyribonucleotides and the subsequent replication of the genome. Key targets within this category include dihydrofolate reductase (DHFR), thymidylate synthase (TS), ribonucleotide reductase (RNR), and various DNA polymerases, which together ensure the availability of DNA precursors and the fidelity of DNA synthesis (Source: NIH, StatPearls). These sites are the primary focus of antimetabolite therapy, where drugs act as structural analogs to natural substrates like folic acid, purines, or pyrimidines to competitively inhibit enzymatic activity or become incorporated into DNA as fraudulent bases (Source: PubChem). This disruption leads to the depletion of nucleotide pools, DNA strand breaks, and the induction of apoptosis, particularly in rapidly dividing cells. Consequently, these targets are central to the treatment of diverse malignancies and autoimmune disorders, although their essential role in normal cell turnover often results in significant side effects such as bone marrow suppression and mucosal damage (Source: Wikipedia, PubMed).

Other names

Antimetabolite targetsDNA synthesis enzymesNucleotide metabolism enzymesDNA replication machineryNucleotide biosynthetic pathways

Inhibition of multiple enzymes involved in the de novo synthesis or salvage pathways of purine and pyrimidine nucleotides, or direct interference with DNA polymerase activity and DNA chain elongation.